Evidence-Based Complementary and Alternative Medicine

Review Article

Clinical Efficacy and Safety of Buyang Huanwu Decoction for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of 19 Randomized Controlled Trials

Table 2

The methodological quality of the included trials.
First author yearABCDEFGHIJKL
Zhang 2010 [12]??−−?−−?++++
Wu 2011 [23]??−−?−−?++++
Zhang 2004 [24]??−−?−−?++++
Guo 2009 [25]??−−?−−?++++
Jia 2010 [26]??−−?−−?++++
Fang 2005 [27]??−−?−−?++++
Zhang 2012 [28]??−−?−−?++++
Li 2011 [29]??−−?−−?++++
Kang 2006 [30]??−−?−−?++++
Lin 2008 [31]??−−?−−?++++
Chen 2007 [32]??−−?−−?++++
Yan 2004 [33]??−−?−−?++++
Cui 2005 [34]??−−?−−?++++
Liu 2010 [35]??−−?−−?++++
Shi 1995 [36]??−−?−−?++++
Run 2001 [37]??−−?−−?++++
Wang 2005 [38]??−−?−−?++++
Lv 2009 [39]?????−−?++++
Zheng 2004 [40]??−−?−−?++++
A: adequate sequence generation; B: concealment of allocation; C: blinding (patient); D: blinding (investigator); E: blinding (assessor); F: incomplete outcome data addressed (ITT analysis); G: incomplete outcome data addressed (dropouts); H: free of selective reporting; I: similarity at baseline; J: cointerventions constant; K: compliance acceptable; L: timing outcome assessments. +Yes, −No, ?Unclear.